Rare Loss-of-Function Mutation in Complement Component C3 Provides Insight into Molecular and Pathophysiological Determinants of Complement Activity
暂无分享,去创建一个
Bo Nilsson | Yiannis N Kaznessis | Daniel Ricklin | John D Lambris | Hui Chen | B. Nilsson | K. Ekdahl | D. Ricklin | J. Lambris | Hui Chen | G. Sfyroera | Y. Kaznessis | E. Reis | E. Wu | Emilia L Wu | Edimara S Reis | Georgia Sfyroera | Kristina N Ekdahl
[1] Z. Fishelson,et al. A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: a clue for vaccine development. , 2011, Molecular immunology.
[2] John D. Lambris,et al. Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms , 2013, The Journal of Immunology.
[3] Dimitrios Morikis,et al. Design and NMR characterization of active analogues of compstatin containing non-natural amino acids. , 2005, Journal of medicinal chemistry.
[4] Piet Gros,et al. Structures of complement component C3 provide insights into the function and evolution of immunity , 2005, Nature.
[5] S. Rodríguez de Córdoba,et al. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway. , 2011, Biochimica et biophysica acta.
[6] Jin Wu,et al. Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation , 2010, Science.
[7] M. Heurich,et al. The complotype: dictating risk for inflammation and infection , 2012, Trends in immunology.
[8] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[9] Daniel Ricklin,et al. Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry. , 2008, Molecular immunology.
[10] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[11] P. Densen,et al. Infectious diseases associated with complement deficiencies , 1991, Clinical Microbiology Reviews.
[12] S. Thiel,et al. Disease-causing mutations in genes of the complement system. , 2011, American journal of human genetics.
[13] H. Colten,et al. Homozygous deficiency of C3 in a patient with repeated infections. , 1972, Lancet.
[14] T. van der Poll,et al. Complement deficiency states and associated infections. , 2011, Molecular immunology.
[15] J. Goodship,et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.
[16] B. Nilsson,et al. Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunction. , 1994, Annals of the rheumatic diseases.
[17] D. Ricklin,et al. Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy. , 2012, Immunobiology.
[18] John D Lambris,et al. Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters. , 2015, Immunobiology.
[19] John D Lambris,et al. Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. , 2006, Journal of medicinal chemistry.
[20] S. Rodríguez de Córdoba,et al. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. , 2010, The Journal of clinical investigation.
[21] V. Frémeaux-Bacchi,et al. A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome , 2012, The Journal of Immunology.
[22] Virgil L. Woods,et al. Rapid refinement of crystallographic protein construct definition employing enhanced hydrogen/deuterium exchange MS. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] John D Lambris,et al. Structure of Compstatin in Complex with Complement Component C3c Reveals a New Mechanism of Complement Inhibition* , 2007, Journal of Biological Chemistry.
[24] D. Ricklin,et al. Compstatin: a complement inhibitor on its way to clinical application. , 2008, Advances in experimental medicine and biology.
[25] M. van Lookeren Campagne,et al. Structural and Functional Analysis of a C3b-specific Antibody That Selectively Inhibits the Alternative Pathway of Complement* , 2009, Journal of Biological Chemistry.
[26] G. Fey,et al. Human complement component C3: cDNA coding sequence and derived primary structure. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] John D Lambris,et al. Structure of complement fragment C 3 b – factor H and implications for host protection by complement regulators , 2009 .
[28] N. S. Laursen,et al. Substrate recognition by complement convertases revealed in the C5–cobra venom factor complex , 2011, The EMBO journal.
[29] W. T. Moore,et al. Kinetic Analysis of the Interactions of Complement Receptor 2 (CR2, CD21) with Its Ligands C3d, iC3b, and the EBV Glycoprotein gp350/2201 , 2001, The Journal of Immunology.
[30] R. Vaughan,et al. Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.
[31] C. Hammer,et al. A rapid FPLC method for purification of the third component of human and guinea pig complement. , 1991, Journal of immunological methods.
[32] Zhongqi Zhang,et al. Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation , 1993, Protein science : a publication of the Protein Society.
[33] B. Nilsson,et al. Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis. , 1992, Arthritis and rheumatism.
[34] P. Hass,et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation , 2006, Nature.
[35] M. Pangburn,et al. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. , 1981, Biochemistry.
[36] D. Ricklin,et al. Structural and functional implications of the alternative complement pathway C 3 convertase stabilized by a staphylococcal inhibitor , 2009 .
[37] John D Lambris,et al. Human genetic deficiencies reveal the roles of complement in the inflammatory network: Lessons from nature , 2009, Proceedings of the National Academy of Sciences.
[38] Peng Liu,et al. Inclusion mechanism of steroid drugs into beta-cyclodextrins. Insights from free energy calculations. , 2009, The journal of physical chemistry. B.
[39] Francesco Saverio Tedesco,et al. Complement in human diseases: Lessons from complement deficiencies. , 2009, Molecular immunology.
[40] John D Lambris,et al. Complement in Immune and Inflammatory Disorders: Therapeutic Interventions , 2013, The Journal of Immunology.
[41] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[42] J. Attia,et al. Human Genome Epidemiology (HuGE) Review Systematic Review and Meta-Analysis of the Association Between Complement Component 3 and Age-related Macular Degeneration: A HuGE Review and Meta- Analysis , 2011 .
[43] P. Taylor,et al. Systemic lupus erythematosus, complement deficiency, and apoptosis. , 2000, Advances in immunology.
[44] John D Lambris,et al. Hydrogen/deuterium exchange mass spectrometry: potential for investigating innate immunity proteins. , 2007, Advances in experimental medicine and biology.
[45] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[46] H. Yamada,et al. Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. , 2013, Molecular immunology.
[47] B. Nilsson,et al. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). , 2008, Molecular immunology.
[48] E. Reis,et al. Clinical Aspects and Molecular Basis of Primary Deficiencies of Complement Component C3 and its Regulatory Proteins Factor I and Factor H , 2006, Scandinavian journal of immunology.
[49] J. Atkinson,et al. Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome , 2007 .
[50] M. Walport,et al. Complement deficiency and immune complex disease , 2005, Springer Seminars in Immunopathology.
[51] W. Fridman,et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. , 2008, Blood.
[52] S. Perkins,et al. New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3 , 2014, Bioscience reports.
[53] Sheng Li,et al. Allosteric inhibition of complement function by a staphylococcal immune evasion protein , 2010, Proceedings of the National Academy of Sciences.